Select Medical
SEM was delisted on the 30th of June, 2026.
227 hedge funds and large institutions have $3.15B invested in Select Medical in 2023 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 61 increasing their positions, 89 reducing their positions, and 27 closing their positions.
434% more call options, than puts
Call options by funds: $443K | Put options by funds: $83K
41% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 27
19% more capital invested
Capital invested by funds: $2.66B → $3.15B (+$496M)
5% more funds holding
Funds holding: 216 → 227 (+11)
5.15% less ownership
Funds ownership: 150.18% → 145.03% (-5.2%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
31% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 89
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$18.2M |
| 2 |
Goldman Sachs
New York
|
+$9.06M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$5.06M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$4.73M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$4.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$63.7M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
-$22.5M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$21.6M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$16.4M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$14.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SC
251
Schubert & Co
Mckinney,
Texas
| – | -$1.29K | -93 | Closed |
|
|
TWD
252
True Wealth Design
Akron,
Ohio
| – | -$1.11K | -80 | Closed |
|
|
CTC
253
Central Trust Company
Jefferson City,
Missouri
| – | -$414 | -30 | Closed |
|
254
Comerica Bank
Dallas,
Texas
| – | +$8.85M | +570,971 | New |
|
SEM Hedge Fund Activity: Q2 2023 in Review
227 of the 6,373 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q2 2023, worth a combined $3.15B — up 19% from $2.66B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new SEM positions and 27 closed out — a net gain of 11 holders — while 61 added to existing stakes and 89 trimmed.
The largest buyer was Bank of America, adding an estimated $18.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $63.7M.
- 227 institutional investors held Select Medical (SEM) as of Q2 2023, up from 216 in Q1 2023.
- Funds reported $3.15B of Select Medical stock for Q2 2023, up 19% quarter-over-quarter.
- 38 funds opened new Select Medical positions in Q2 2023 and 27 closed out, a net change of +11 holders.
- The largest Select Medical buyer in Q2 2023 was Bank of America, an estimated $18.2M added.
- The largest Select Medical seller in Q2 2023 was T. Rowe Price Associates, an estimated $63.7M sold.
Based on aggregated 13F filings for Q2 2023.